Navigation Links
VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials
Date:5/23/2013

SAN MARINO, Calif., May 23, 2013 /PRNewswire/ -- VG Energy, an agricultural biotech company, announces today a strategic alliance with DAK Renewable Research to conduct field trials using LipidMax to increase the corn oil yield. VG Energy is a majority owned subsidiary of VG Life Sciences, Inc. (OTC Pink: VGLS).

VG Energy's exclusively licensed compound LipidMax selectively inhibits certain metabolic pathways to increase the oil yield in plants, possessing a wide variety of applications including biofuel and vegetable oils.  This important discovery is called Metabolic Disruption Technology.

DAK Renewable Research headquartered in Brandon, South Dakota brings agricultural innovations together with investors. It is primarily focused on developing viable and cost-effective green energy solutions. DAK is providing twelve 2,000 ft2 plots in South Dakota to measure the effect of LipidMax in corn oil production and test the robustness of LipidMax in field conditions. The compound will be applied at multiple stages in the growth cycle of the corn. The crop will reach maturity in mid-October and results will be announced shortly thereafter. All data from the results will be exclusively owned by VG Energy.

"We are excited to see our product take this leap from the lab to the field," says Haig Keledjian , CEO of VG Life Sciences. "Our goal with these tests is to further approach market commercialization and getting LipidMax closer to being in the hands of farmers."

The inventor of Metabolic Disruption Technology (MDT) is Karen Newell , PhD at Texas A&M University School of Medicine and Chief Scientist at VG Life Sciences. Dr. Marty Dickman , PhD at Texas A&M University, is the Chief Scientific Advisor for VG Life Sciences on the agricultural side of the business. Together Dr. Newell and Dr. Dickman are testing and developing exciting MDT agricultural applications including LipidMax.

"We have seen very positive lab results on oil yields using LipidMax and now we are anxious to see if we get similar yields in the field," said Dr. Dickman. "Yield is the watchword of every farmer and our partners at DAK Renewable Research are the perfect facilitators to bring this all together."

About VG Energy
VG Energy, Inc. is an agricultural biotech company that is a majority-owned subsidiary of VG Life Sciences Inc., a biotech company researching treatments for drug-resistant cancer, Lyme disease, Strep, Staph and Sepsis, and HIV/AIDS. VG Energy holds the exclusive worldwide license to the Metabolic Disruption Technology (MDT) patent rights for use in the increase of production of various oils from algae, plants and seeds. VG Energy's pivotal discoveries could allow the agricultural industry to increase production yields. For more information, please visit www.VGEnergy.net or www.VGLifeSciences.com.

About DAK Renewable Research
DAK Renewable Energy is committed to working towards a greener environment through the development, management and investment in projects related to ethanol, wind and biofuels. The directors of DAK are supported by a team of talented individuals with extensive experience in agricultural, education and business development.  For more information, please visit www.dakrenewableenergy.com.

Safe Harbor Statement and Forward-Looking Statements
This news release may contain forward-looking statements that involve risks and uncertainties associated with financial projections, milestone timelines, clinical development, regulatory approvals and other risks described by VG Life Sciences from time to time in its periodic reports. None of VG Life Sciences' drug compounds are approved by the US FDA or by any comparable regulatory agencies elsewhere in the world. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by VG Life Sciences or any other person that the objectives and plans of VG Life Sciences will be achieved.

CONTACT:
Alexandria Sumner , Marketing Consultant
VG Energy, Inc.
Phone:  (805) 679-6763
Email:  Alex@vglifesciences.com


'/>"/>
SOURCE VG Energy
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. How graphene and friends could harness the Suns energy
2. Leviticus Cardio Ltd. Completes a Successful Animal Trial for its Wireless Energy System for VADs
3. South Dakota School of Mines & Technology Researchers Document Splitting Water Molecules in Multiple Thermochemical Cycles with Goal to Sustain Hydrogen Energy
4. North Carolina A&T State University Crowned Champion in $100,000 ACC Clean Energy Challenge
5. Israel’s Top BioEnergy Researchers Are Arriving Today at Oak Ridge National Laboratory For Deliberations to Establish U.S.-Israel Collaboration
6. Israel’s BioEnergy Leaders Meet for Two Days of Deliberations with U.S. Government Counterparts - Following Wednesday White House Briefing
7. Top BioEnergy Researchers and Innovators Arriving Next Week to Foster U.S.-Israel Collaboration
8. Nanowires have the power to revolutionize solar energy
9. China Industry Reports: 2013 Research on Swine Industry Chain, Human Tetanus Immunoglobulin, Power Energy Storage Battery and Wind Power Lubricating Grease at ReportsnReports.com
10. ACC Clean Energy Challenge Announces Elite Eight Plus Two, Will Vie to Reach Final Four
11. Ultra Light Startups Hosts Future Energy Investor Feedback Forum at MIT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... DUBLIN , Feb 22, 2017 ... addition of the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, ... Forecasts (2016-2021)" report to their offering. ... Global Biological Crop Protection Market is ... The strong growth in biopesticide or biological crop protection ...
(Date:2/22/2017)... 2017 Aethlon Medical, Inc. (Nasdaq: ... that validated the ability of the Aethlon Hemopurifier® to ... mortality in immune-suppressed sepsis patients and also contribute to ... objective of the study was to validate the ... (EBV) and Herpes Simplex virus 1 (HSV1) by the ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... announced the addition of Tom Perkins as European director. Operating from Pennside’s Zurich ... to Pennside. , Perkins joins Pennside after more than a decade with ...
(Date:2/22/2017)... PARK, N.C., Feb. 22, 2017  United Therapeutics Corporation ... financial results for the fourth quarter and year ... financial results reflect continued growth as net revenues ... said Martine Rothblatt, Ph.D., United Therapeutics, Chairman and ... ability to develop and advance our growing product ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... the LEERINK Partners 6th Annual Global Healthcare Conference at ... 15, 2017 at 10 a.m. Eastern Time. ... accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will be ... Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):